60 Degrees Pharmaceuticals, Inc. (SXTP )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol SXTP
- Company 60 Degrees Pharmaceuticals, Inc.
- Price $1.03
- Changes Percentage 13.19
- Change 0.12
- Day Low $1
- Day High $1.08
- Year High $12.45
- Year Low $0.85
- Market Cap $3,322,986
- Price Avg 50 EMA (D) $1.41
- Price Avg 200 EMA (D) $1.95
- Exchange NASDAQ
- Volume 72,395
- Average Volume 137,456
- Open $1
- Previous Close $0.91
- EPS 0.07
- PE 14.71
- Earnings Announcement 2025-11-13 05:00:00
- Shares Outstanding $3,226,200
Company brief: 60 DEGREES PHARMACEUTICALS, INC. (SXTP )
- Healthcare
- Biotechnology
- Dr. Geoffrey Stuart Dow
- https://60degreespharma.com
- US
- N/A
- 07-12-2023
- US83006G1040
60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.